JP Morgan Chase
OKUR

JP Morgan Chase’s OnKure Therapeutics OKUR Stock Holding History

JP Morgan Chase’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.1K Buy
10,911
+10,866
+24,147% +$46.6K ﹤0.01% 6428
2026
Q1 		$171 Sell
45
-500
-92% -$1.54K ﹤0.01% 7270
2025
Q4 		$1.58K Buy
545
+122
+29% +$365 ﹤0.01% 6978
2025
Q3 		$1.16K Buy
423
+269
+175% +$666 ﹤0.01% 6975
2025
Q2 		$368 Sell
154
-77
-33% -$202 ﹤0.01% 6729
2025
Q1 		$993 Sell
231
-106
-31% -$596 ﹤0.01% 6631
2024
Q4 		$2.9K Sell
337
-430
-56% -$6.51K ﹤0.01% 6593
2024
Q3 		$13K Sell
767
-25
-3% -$370 ﹤0.01% 6320
2024
Q2 		$12K Sell
792
-712
-47% -$12.1K ﹤0.01% 6224
2024
Q1 		$25K Sell
1,504
-114
-7% -$1.88K ﹤0.01% 6168
2023
Q4 		$25.9K Buy
1,618
+763
+89% +$47.5K ﹤0.01% 6190
2023
Q3 		$65.1K Buy
855
+84
+11% +$5.71K ﹤0.01% 5705
2023
Q2 		$50.6K Sell
771
-1,207
-61% -$97.2K ﹤0.01% 5718
2023
Q1 		$118K Buy
1,978
+31
+2% +$1.12K ﹤0.01% 5350
2022
Q4 		$45K Sell
1,947
-689
-26% -$18.3K ﹤0.01% 5665
2022
Q3 		$88K Buy
+2,636
New +$86.6K ﹤0.01% 5340
2022
Q2 		– Sell
-408
Closed -$12K – 6960
2022
Q1 		$12K Buy
408
+164
+67% +$9.18K ﹤0.01% 6180
2021
Q4 		$21K Sell
244
-68
-22% -$4.99K ﹤0.01% 6206
2021
Q3 		$23K Sell
312
-467
-60% -$39.6K ﹤0.01% 6022
2021
Q2 		$73K Buy
+779
New +$86.9K ﹤0.01% 5636

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase's OKUR Position: Q2 2026 in Review

JP Morgan Chase increased its OnKure Therapeutics (OKUR) stake by 24,147% in Q2 2026, buying an estimated $46.6K and bringing the position to 10,911 shares worth $49.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6428.

JP Morgan Chase first reported a position in OKUR in Q2 2021 and has held it in 20 quarters since. The position peaked at $118K in Q1 2023. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • JP Morgan Chase held 10,911 shares of OnKure Therapeutics worth $49.1K as of Q2 2026.
  • JP Morgan Chase bought 10,866 OnKure Therapeutics shares in Q2 2026, an estimated $46.6K.
  • OnKure Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6428 holding.
  • JP Morgan Chase first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's OnKure Therapeutics position peaked at $118K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.